1. GCKR polymorphism influences liver fat content in patients with type 2 diabetes
- Author
-
Jean-Michel Petit, Marie-Claude Brindisi, Laurence Duvillard, Patrick Hillon, Boris Guiu, Fabien Rollot, David Masson, Benjamin Bouillet, Perrine Buffier, Bruno Vergès, Jean-Pierre Cercueil, Lipides - Nutrition - Cancer (U866) ( LNC ), Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ), Service d'Endocrinologie, Diabétologie et Maladies Métaboliques (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'Hépato-Gastro-Entérologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon, and Conseil Regional de Bourgogne (AOI)
- Subjects
Male ,0301 basic medicine ,Magnetic Resonance Spectroscopy ,Steatosis ,MESH : Polymorphism, Genetic ,Endocrinology, Diabetes and Metabolism ,MESH : Aged ,Type 2 diabetes ,Body Mass Index ,chemistry.chemical_compound ,0302 clinical medicine ,Endocrinology ,MESH : Diabetes Mellitus, Type 2 ,MESH : Lipid Metabolism ,MESH : Female ,MESH : Adaptor Proteins, Signal Transducing ,education.field_of_study ,Glucokinase regulatory protein ,1H-MR spectroscopy ,General Medicine ,Middle Aged ,MESH : Adult ,[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism ,MESH : Non-alcoholic Fatty Liver Disease ,Metformin ,Liver ,Female ,medicine.drug ,GCKR ,Adult ,Heterozygote ,medicine.medical_specialty ,MESH : Heterozygote ,MESH : Male ,Population ,030209 endocrinology & metabolism ,Biology ,03 medical and health sciences ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,medicine ,Humans ,MESH : Middle Aged ,education ,Alleles ,Adaptor Proteins, Signal Transducing ,Aged ,Polymorphism, Genetic ,Triglyceride ,MESH : Humans ,MESH : Liver ,Lipid Metabolism ,medicine.disease ,MESH : Body Mass Index ,030104 developmental biology ,Diabetes Mellitus, Type 2 ,chemistry ,biology.protein ,MESH : Magnetic Resonance Spectroscopy ,MESH : Alleles ,Body mass index ,Non-alcoholic fatty liver disease - Abstract
IF 3.074; International audience; It has recently been shown that an allele in the glucokinase regulatory protein (GCKR) gene was associated with increased liver fat content in obese children. In this study, we set out to determine whether GCKR rs1260326 polymorphism was associated with liver fat content in patients with type 2 diabetes.Three hundred and eight patients with type 2 diabetes were included in this study. Liver fat content was evaluated using 1H-MR spectroscopy.In our population, carriers of the rs1260326 minor T allele had a higher liver fat content than did carriers of the C allele homozygote (12.4 +/- A 9.6 vs. 10.3 +/- A 9.1 %, p = 0.03). The number of patients with steatosis was significantly higher in minor T allele carriers than in C allele homozygote carriers (70.7 vs. 55.4 %; p = 0.008). In multivariate analysis, the predictive variables for steatosis were BMI [odds ratio (OR) 1.08; 95 % confidence interval (CI) 1.03-1.13; p = 0.002], statin therapy (yes) [OR 0.54; 95 % CI 0.31-0.94; p = 0.03], metformin therapy (yes) [OR 2.67; 95 % CI 1.50-4.75; p < 0.001], and rs1260326 GCKR polymorphism (TT+CT) [OR 1.99; 95 % CI 1.14-3.47; p = 0.01].This study shows that in patients with type 2 diabetes who were not selected for liver abnormalities, liver fat content was related to GCKR rs1260326 polymorphism independent of BMI, triglyceride levels, and age.
- Published
- 2016